Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Dec 9, 2019 at 10:40 AM EST

Why These 3 Biotechs More Than Doubled on Monday

Monday was a breakout day for a few biotech companies. Some made absolutely massive runs, practically doubling and then some.…

Chris Lange | Dec 6, 2019 at 11:25 AM EST

Is the Sage Therapeutics Implosion Overblown?

Sage Therapeutics shareholders took a bath on Thursday after results from its late-stage major depressive disorder trial came public.

Chris Lange | Dec 5, 2019 at 11:20 AM EST

Thursday’s Biggest Biotech Movers

Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a…

Chris Lange | Dec 4, 2019 at 12:00 PM EST

Why This Transfusion-Dependent Beta-Thalassemia Trial Is Taking Off

Protagonist Therapeutics shares jumped on Wednesday after the company announced preliminary results from its midstage study for patients with transfusion-dependent…

Chris Lange | Dec 3, 2019 at 12:10 PM EST

Are Audentes Shareholders Getting Enough in the Acquisition?

Audentes Therapeutics shares more than doubled on Tuesday after the firm announced that it would be acquired by Astellas. Although…

Chris Lange | Dec 3, 2019 at 11:40 AM EST

How Aslan Pharma Is Capitalizing on Its Huge Atopic Dermatitis Success

Aslan Pharmaceuticals has been on a roller coaster for the past two weeks. Now the stock is coming back to…

Chris Lange | Dec 3, 2019 at 10:05 AM EST

Why Mixed Results From This Chronic Kidney Disease Study Aren’t That Great

Cara Therapeutics shares were crushed on Tuesday after the firm announced results from its midstage trial in patients with chronic…

Chris Lange | Dec 3, 2019 at 9:40 AM EST

Why Investors Shouldn’t Sleep on This Narcolepsy Study

Axsome Therapeutics shares jumped early on Tuesday after the firm announced positive results from its midstage narcolepsy trial.

Paul Ausick | Dec 2, 2019 at 1:20 PM EST

Study: The Poor Get Less Sleep, Leading to Greater Risk of Heart Disease

Research shows that a lack of sleep is a significant factor in the occurrence of heart disease among low-income people.

Chris Lange | Dec 2, 2019 at 10:15 AM EST

Why This Atopic Dermatitis Study Was So Well Received

Aslan Pharmaceuticals shares jumped on Monday after the firm announced positive preliminary data from the lowest dose cohort of its…

Chris Lange | Dec 2, 2019 at 9:40 AM EST

Why This Seizure Treatment Could Be the Next Big Thing

Aquestive Therapeutics shares jumped early on Monday after the firm announced the completion of its rolling submission of a New…

Chris Lange | Dec 1, 2019 at 2:25 PM EST

Major Biopharma Catalysts on the December FDA Calendar

Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates…

Chris Lange | Nov 29, 2019 at 10:40 AM EST

Major Biopharma Catalysts on the December FDA Calendar

Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates…

Chris Lange | Nov 27, 2019 at 9:00 AM EST

Big Pharma Short Sellers Hike Their Bets

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Nov 27, 2019 at 8:40 AM EST

Short Sellers Run For Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data…

1 … 76 77 78 79 80 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why These 3 Biotechs More Than Doubled on Monday

Is the Sage Therapeutics Implosion Overblown?

Thursday’s Biggest Biotech Movers

Why This Transfusion-Dependent Beta-Thalassemia Trial Is Taking Off

Are Audentes Shareholders Getting Enough in the Acquisition?

How Aslan Pharma Is Capitalizing on Its Huge Atopic Dermatitis Success

Why Mixed Results From This Chronic Kidney Disease Study Aren’t That Great

Why Investors Shouldn’t Sleep on This Narcolepsy Study

Study: The Poor Get Less Sleep, Leading to Greater Risk of Heart Disease

Why This Atopic Dermatitis Study Was So Well Received

Why This Seizure Treatment Could Be the Next Big Thing

Major Biopharma Catalysts on the December FDA Calendar

Major Biopharma Catalysts on the December FDA Calendar

Big Pharma Short Sellers Hike Their Bets

Short Sellers Run For Cover From Major Biotechs

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

Why These 3 Biotechs More Than Doubled on Monday

Is the Sage Therapeutics Implosion Overblown?

Thursday’s Biggest Biotech Movers

Why This Transfusion-Dependent Beta-Thalassemia Trial Is Taking Off

Are Audentes Shareholders Getting Enough in the Acquisition?

How Aslan Pharma Is Capitalizing on Its Huge Atopic Dermatitis Success

Why Mixed Results From This Chronic Kidney Disease Study Aren’t That Great

Why Investors Shouldn’t Sleep on This Narcolepsy Study

Study: The Poor Get Less Sleep, Leading to Greater Risk of Heart Disease

Why This Atopic Dermatitis Study Was So Well Received

Why This Seizure Treatment Could Be the Next Big Thing

Major Biopharma Catalysts on the December FDA Calendar

Major Biopharma Catalysts on the December FDA Calendar

Big Pharma Short Sellers Hike Their Bets

Short Sellers Run For Cover From Major Biotechs

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up